Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

ZIEN Medical Technologies, LLC

United States·US-MF-000004717

Last updated September 18, 2026

About

ZIEN Medical Technologies: Your partner for faster medical device development, ISO 13485 compliance, and contract manufacturing.

From the manufacturer's own website. Source

What ZIEN Medical Technologies, LLC makes

ZIEN Medical Technologies manufactures single-use general-purpose syringes, thrombectomy suction catheters, and vascular guide-catheters designed for interventional procedures. Their portfolio also includes thrombectomy tubing sets, vascular microcatheters, and basic peripheral angioplasty balloon catheters, alongside reusable urine flowmeters and single-use scalpels. Specific products include mechanical thrombectomy systems like the Control 7F and 11F, as well as microcatheters such as the XO Cross 35 and Landmark Catheter Introducer Kit.

The company’s devices are classified under FDA regulations as Class I, Class II, and Class IIa, with listings in the FDA’s Unique Device Identifier (UDI) database and the EU’s eudamed registry. The manufacturer is based in the United States, where its products are subject to U.S. medical device regulations.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does ZIEN Medical Technologies manufacture?

ZIEN Medical Technologies produces a range of medical devices primarily used in interventional and procedural settings. Their portfolio includes single-use general-purpose syringes, thrombectomy suction catheters, and vascular guide-catheters. They also manufacture thrombectomy tubing sets (non-electronic), vascular microcatheters, basic peripheral angioplasty balloon catheters, reusable urine flowmeters, and single-use scalpels. These devices are designed for applications like vascular interventions, thrombectomy procedures, and general surgical use.

Where is ZIEN Medical Technologies based, and how does this affect its devices?

ZIEN Medical Technologies is based in the United States, which means its devices are subject to U.S. medical device regulations, including FDA oversight. The company’s products are designed and manufactured in compliance with these regulations, ensuring they meet the necessary safety, performance, and labeling requirements for the U.S. market. This also influences how the devices are classified and registered, such as through the FDA’s UDI database.

Which regulatory registries list ZIEN Medical Technologies’ devices?

ZIEN Medical Technologies’ devices are listed in two key regulatory registries: the FDA’s Unique Device Identifier (UDI) database and the EU’s eudamed registry. These listings help ensure transparency and traceability of the devices in both the U.S. and European markets, allowing healthcare providers, regulators, and other stakeholders to verify product details and compliance status.

How are ZIEN Medical Technologies’ devices classified under FDA regulations?

ZIEN Medical Technologies’ devices are classified under three FDA categories: Class I, Class II, and Class IIa. The classification depends on the device’s risk level and intended use. For example, general-purpose syringes and single-use scalpels are typically Class I, while more complex devices like thrombectomy suction catheters or vascular guide-catheters may fall under Class II or Class IIa due to their higher risk and regulatory controls. This classification determines the regulatory pathway and requirements for each device.

Are ZIEN Medical Technologies’ devices used in both single-use and reusable applications?

Yes, ZIEN Medical Technologies manufactures devices for both single-use and reusable applications. Most of their products, such as syringes, thrombectomy catheters, and scalpels, are designed for single-use to ensure patient safety and sterility. However, they also produce reusable devices like urine flowmeters, which are intended for repeated use in clinical settings with proper cleaning and sterilization protocols.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
2490 South 300 West, Utah, United States
LinkedIn
—
Facebook
—
Phone
+1 385 444 2666
PRRC Contact
Adam Howell
EUDAMED SRN
US-MF-000004717
FDA FEI Number
—
DUNS Number
—

Catalogue (87)

Page 1 of 2
DeviceModel / ReferenceRegistriesClassStatus
SAM IO ® Needle - 45mm IO807
EUDAMED
Class IIaActive
XableCath XC-035-090A
FDA UDI
Class IIUnknown
Control 11F Mechanical Thrombectomy System A11-090
FDA UDI
Class IIActive
XableCath XC-018-090A
FDA UDI
Class IIUnknown
Stream Dx SDX02
FDA UDI
Class IIActive
XO Cross 35 C35-090-H
FDA UDI
Class IIActive
Landmark Catheter Introducer Kit LR-KIT
FDA UDI
Class IIActive
XO Score S6.25-065
FDA UDI
Class IIActive
PenBlade Safety Scalpel #10 Blade
FDA UDI
Class IActive
PowrSyringe PWR-10
FDA UDI
Class IIUnknown
Control 7F Mechanical Thrombectomy System A7-090
FDA UDI
Class IIActive
XO Cross 14 C14-135-H
FDA UDI
Class IIActive
PenBlade Safety Scalpel #11P Blade
FDA UDI
Class IActive
XableCath XC-035-145A
FDA UDI
Class IIUnknown
Control 7F Mechanical Thrombectomy System A7-060
FDA UDI
Class IIActive
XO Cross 14 C14-175
FDA UDI
Class IIUnknown
XO Cath E20-130-S
FDA UDI
Class IIActive
Control 7F Mechanical Thrombectomy System ASP-1033
FDA UDI
Class IIActive
XO Cross 35 C35-135-H
FDA UDI
Class IIActive
XableCath XC-014-145B
FDA UDI
Class IIUnknown
Cats CATS-D
FDA UDI
Class IIActive
XableCath XC-014-090B
FDA UDI
Class IIUnknown
The Morgan Lens Ocular Irrigation Convenience Kit MT2063
FDA UDI
Class IActive
XO Cross 14 C14-090
FDA UDI
Class IIUnknown
XableCath XC-014-090A
FDA UDI
Class IIUnknown
XO Cross 14 C14-175-H
FDA UDI
Class IIActive
XO Cross 14 C14-135
FDA UDI
Class IIUnknown
Aspire Max 6 Aspiration Catheter 55cm A6-055
FDA UDI
Class IIUnknown
XO Cross 35 C35-175-H
FDA UDI
Class IIActive
XO Cross 35 C35-135
FDA UDI
Class IIUnknown
XableCath XC-014-065B
FDA UDI
Class IIUnknown
Control 11F Mechanical Thrombectomy System ASP-1036
FDA UDI
Class IIActive
XableCath XC-035-145B
FDA UDI
Class IIUnknown
XO Cath E20-130-B
FDA UDI
Class IIActive
Control 7F Mechanical Thrombectomy System ASP-1013
FDA UDI
Class IIActive
Control 10T Mechanical Thrombectomy Filter ASP-1039
FDA UDI
Class IIActive
Control Mechanical Aspirator 30ml ASP-1029
FDA UDI
Class IIActive
Landmark LR-N-059
FDA UDI
Class IIActive
XableCath XC-035-065A
FDA UDI
Class IIUnknown
Control RX-LP Mechanical Thrombectomy System ASP-1001
FDA UDI
Class IIActive
XableCath XC-035-090B
FDA UDI
Class IIUnknown
Control 9F Mechanical Thrombectomy System, 60cm A9-060
FDA UDI
Class IIActive
XableCath XC-018-145B
FDA UDI
Class IIUnknown
MorTan MT2000
FDA UDI
Class IActive
XO Score S6.50-065
FDA UDI
Class IIActive
Syntervention 4011
FDA UDI
Class IActive
Knight Microcatheter 2P0-130-B
FDA UDI
Class IIActive
Control RX-LP Mechanical Thrombectomy System, 136cm ARX-LP6
FDA UDI
Class IIActive
XableCath XC-035-065B
FDA UDI
Class IIUnknown
Control 10T Mechanical Thrombectomy System Tubing MT10-100
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (1)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Zien Medical Technologies, LLC has one FDA recall record initiated on August 18, 2015, which is marked as terminated. The recall was due to cracks found in the PET tray of a limited batch of sterile products, potentially compromising the sterile barrier integrity. The affected lots were produced between September 2014 and July 2015.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Aug 18, 2015Z-2800-2015—terminated

Cracks were discovered in the PET tray of a small population of sterile product. These cracks create a risk of loss of sterile barrier for the product. Sampling and root cause analysis indicated that the risk could extend throughout the lots manufactured from September 2014-July 2015. This led to the decision to recall the product.